abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 -R 4 , Q, Z, r, and p are as defined herein. Compounds of the present invention are useful in the treatment of diseases associated with FAK overexpression, including proliferative diseases. |